Romatolojik Hastalıkların Nörolojik Manifestasyonları: Çocukluk Çağı Sjögren Sendromu ve Çocukluk Çağı Sistemik ve Lokalize Skleroderma’da Nörolojik Tutulum

Basiaga, M. L., Stern, S. M., Mehta, J. J., Edens, C., Randell, R. L., Pomorska, A., Irga-Jaworska, N., Ibarra, M. F., Bracaglia, C., Nicolai, R., Susic, G., Boneparth, A., Srinivasalu, H., Dizon, B., Kamdar, A. A., Goldberg, B., Knupp-Oliveira, S., Antón, J., Mosquera, J. M., Appenzeller, S., Childhood Arthritis and Rheumatology Research Alliance and the International Childhood Sjögren Syndrome Workgroup (2021). Childhood Sjögren syndrome: features of an international cohort and application of the 2016 ACR/EULAR classification criteria. Rheumatology (Oxford, England), 60(7), 3144–3155. https://doi.org/10.1093/rheumatology/keaa757

Lori Tucker and Coziana Ciurtin, Sjögren Syndrome and Immunoglobulin-G4 Disease, Textbook of Pediatric Rheumatology Eighth Edition, 29, 417-426,e3

Sözeri B. Sjögren sendromu. Yüksel S, editor. Pediatrik Romatolojide Sistemik Bağ Dokusu Hastalıkları. 1. Baskı. Ankara: Türkiye Klinikleri; 2021. p.74-80.

Carsons SE, Patel BC. Sjogren Syndrome. [Updated 2023 Jul 31]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK431049/

Brito-Zerón P, Baldini C, Bootsma H, et al. Sjögren syndrome. Nat Rev Dis Primers. 2016;2:16047. Published 2016 Jul 7.

Imgenberg-Kreuz, J., Rasmussen, A., Sivils, K., & Nordmark, G. (2021). Genetics and epigenetics in primary Sjögren's syndrome. Rheumatology (Oxford, England), 60(5), 2085–2098. https://doi.org/10.1093/rheumatology/key330

Zhao, J., Chen, Q., Zhu, Y. et al. Nephrological disorders and neurological involvement in pediatric primary Sjogren syndrome:a case report and review of literature. Pediatr Rheumatol 18, 39 (2020). https://doi.org/10.1186/s12969-020-00431-y))****

Shiboski, C. H., Shiboski, S. C., Seror, R., Criswell, L. A., Labetoulle, M., Lietman, T. M., Rasmussen, A., Scofield, H., Vitali, C., Bowman, S. J., Mariette, X., & International Sjögren's Syndrome Criteria Working Group (2017). 2016 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Primary Sjögren's Syndrome: A Consensus and Data-Driven Methodology Involving Three International Patient Cohorts. Arthritis & rheumatology (Hoboken, N.J.), 69(1), 35–45. https://doi.org/10.1002/art.39859

Carvajal Alegria G, Guellec D, Mariette X on behalf of the Assessment of Systemic Signs and Evolution in Sjögren's Syndrome (ASSESS) group, et al, Epidemiology of neurological manifestations in Sjögren's syndrome: data from the French ASSESS Cohort, RMD Open 2016;2:e000179. doi: 10.1136/rmdopen-2015-000179

Delalande, Sophie; de Seze, Jérôme; Fauchais, Anne-Laure; Hachulla, Eric; Stojkovic, Tanya; Ferriby, Didier; Dubucquoi, Sylvain; Pruvo, Jean-Pierre; Vermersch, Patrick; Hatron, Pierre-Yves. Neurologic Manifestations in Primary Sjögren Syndrome: A Study of 82 Patients. Medicine 83(5):p 280-291, September 2004. | DOI: 10.1097/01.md.0000141099.53742.16

Konak, Hatice Ecem; Gök, Kevser; Armağan, Berkan; Güven, Serdar Can1; Atalar, Ebru; Apaydın, Hakan; Maraş, Yüksel; Erten, Şükran. Neurological Involvement in Patients with Primary Sjögren’s Syndrome: A Retrospective Cross-Sectional Study. Annals of Indian Academy of Neurology 26(4):p 424-430, Jul–Aug 2023. | DOI: 10.4103/aian.aian_138_23

Price, E. J., Benjamin, S., Bombardieri, M., Bowman, S., Carty, S., Ciurtin, C., Crampton, B., Dawson, A., Fisher, B. A., Giles, I., Glennon, P., Gupta, M., Hackett, K. L., Larkin, G., Ng, W.-F., Ramanan, A. V., Rassam, S., Rauz, S., Smith, G., ... Walsh, S. B. (2024). British Society for Rheumatology guideline on management of adult and juvenile onset Sjögren disease. Rheumatology (Oxford, England), Article keae152. Advance online publication. https://doi.org/10.1093/rheumatology/keae152

Yokogawa, N., Lieberman, S. M., Sherry, D. D., & Vivino, F. B. (2016). Features of childhood Sjögren's syndrome in comparison to adult Sjögren's syndrome: considerations in establishing child-specific diagnostic criteria. Clinical and experimental rheumatology, 34(2), 343–351

Gong, Y., Liu, H., Li, G., Zhang, T., Li, Y., Guan, W., Zeng, Q., Lv, Q., Zhang, X., Yao, W., Shi, Y., Xu, H., & Sun, L. (2023). Childhood-onset primary Sjögren's syndrome in a tertiary center in China: clinical features and outcome. Pediatric rheumatology online journal, 21(1), 11. https://doi.org/10.1186/s12969-022-00779-3)

Leone MC, Alunno A, Cafaro G, et al. The clinical spectrum of primary Sjögren’s syndrome: beyond exocrine glands. Reumatismo. 2017;69(3):93-100.

Perzyńska-Mazan, J., Maślińska, M., & Gasik, R. (2018). Neurological manifestations of primary Sjögren's syndrome. Reumatologia, 56(2), 99–105. https://doi.org/10.5114/reum.2018.75521

McCoy, S. S., & Baer, A. N. (2017). Neurological Complications of Sjögren's Syndrome: Diagnosis and Management. Current treatment options in rheumatology, 3(4), 275–288. https://doi.org/10.1007/s40674-017-0076-9

Barsottini, O. G. P., Moraes, M. P. M., Fraiman, P. H. A., Marussi, V. H. R., Souza, A. W. S., Braga Neto, P., & Spitz, M. (2023). Sjogren's syndrome: a neurological perspective. Síndrome de Sjogren: uma perspectiva neurológica. Arquivos de neuro-psiquiatria, 81(12), 1077–1083. https://doi.org/10.1055/s-0043-1777105

Gmuca S, Lieberman SM, Mehta J. Pediatric neuromyelitis optica spectrum disorder and Sjogren Syndrome: more common than previously thought? J Rheumatol. 2017;44(6):959–960.

Park JH, Hwang J, Min JH, et al. Presence of anti-Ro/SSA antibody may be associated with anti-aquaporin-4 antibody positivity in neuromyelitis optic spectrum disorder. J Neurol Sci. 2015;348:132–135.

Ramos-Casals, M., Brito-Zerón, P., Bombardieri, S., Bootsma, H., De Vita, S., Dörner, T., Fisher, B. A., Gottenberg, J. E., Hernandez-Molina, G., Kocher, A., Kostov, B., Kruize, A. A., Mandl, T., Ng, W. F., Retamozo, S., Seror, R., Shoenfeld, Y., Sisó-Almirall, A., Tzioufas, A. G., Vitali, C., … EULAR-Sjögren Syndrome Task Force Group (2020). EULAR recommendations for the management of Sjögren's syndrome with topical and systemic therapies. Annals of the rheumatic diseases, 79(1), 3–18. https://doi.org/10.1136/annrheumdis-2019-216114

Wakasugi D, Kato T, Gono T, Ito E, Nodera H, Kawaguchi Y, et al. Extreme efficacy of intravenous immunoglobulin therapy for severe burning pain in a patient with small fiber neuropathy associated with primary Sjogren’s syndrome. Modern Rheumatol/Jpn Rheumat Assoc. 2009;19(4):437–40. 10.1007/s10165-009-0180-2

Morozumi S, Kawagashira Y, Iijima M, Koike H, Hattori N, Katsuno M, et al. Intravenous immunoglobulin treatment for painful sensory neuropathy associated with Sjogren’s syndrome. J Neurol Sci. 2009;279(1-2):57–61. 10.1016/j.jns.2008.12.018.

Yıldız M, Adroviç A, Kasapçopur Ö. Jüvenil skleroderma: Patogenez, klinik bulgular ve te- davi. Sözeri B, editör. Çocukluk Çağında Her Yönüyle Otoimmün Romatizmal Hastalıklar. 1. Baskı. Ankara: Türkiye Klinikleri; 2021. p.77-84).

Kathryn S. Torok and Anne M. Stevens, Juvenile Systemic Sclerosis, Textbook of Pediatric Rheumatology,Eighth Edition 27, 377-401.e8

Stevens, A. M., Torok, K. S., Li, S. C., Taber, S. F., Lu, T. T., & Zulian, F. (2019). Immunopathogenesis of Juvenile Systemic Sclerosis. Frontiers in immunology, 10, 1352. https://doi.org/10.3389/fimmu.2019.01352

Sobolewski, P., Maślińska, M., Wieczorek, M., Łagun, Z., Malewska, A., Roszkiewicz, M., Nitskovich, R., Szymańska, E., & Walecka, I. (2019). Systemic sclerosis - multidisciplinary disease: clinical features and treatment. Reumatologia, 57(4), 221–233. https://doi.org/10.5114/reum.2019.87619 )

Martini, G., Foeldvari, I., Russo, R., Cuttica, R., Eberhard, A., Ravelli, A., Lehman, T. J., de Oliveira, S. K., Susic, G., Lyskina, G., Nemcova, D., Sundel, R., Falcini, F., Girschick, H., Lotito, A. P., Buoncompagni, A., Sztajnbok, F., Al-Mayouf, S. M., Orbàn, I., Ferri, C., … Juvenile Scleroderma Working Group of the Pediatric Rheumatology European Society (2006). Systemic sclerosis in childhood: clinical and immunologic features of 153 patients in an international database. Arthritis and rheumatism, 54(12), 3971–3978. https://doi.org/10.1002/art.22207)

Rongioletti F, Ferreli C, Atzori L, Bottoni U, Soda G. Scleroderma with an update about clinico-pathological correlation. G Ital Dermatol Venereol.2018;153(2):208-215.

Kızıldağ Z, Ünsal ŞE. Juvenil lokalize sklero- derma. Yüksel S, editör. Pediatrik Romatolojide Sistemik Bağ Dokusu Hastalıkları. 1. Baskı. An- kara: Türkiye Klinikleri; 2021. p.57-64.

Suzanne C. Li and Elena Pope, Localized Scleroderma and Eosinophilic Fasciitis , Textbook of Pediatric Rheumatology,Eighth Edition, 28, 402-416.e6

Amaral, T. N., Marques Neto, J. F., Lapa, A. T., Peres, F. A., Guirau, C. R., & Appenzeller, S. (2012). Neurologic involvement in scleroderma en coup de sabre. Autoimmune diseases, 2012, 719685. https://doi.org/10.1155/2012/719685).